On the other hand, patients with malignant tenosynovial giant cell tumors, defined by COL6A3::CSF1 fusion and low percentage neoplastic cells, are better diagnosed by target PCR instead of OGM [31]. The gene discussed is COL6A3; the disease is tenosynovial giant cell tumor.